These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 789408)

  • 1. Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy.
    Byron PR; Mallick NP; Taylor G
    J Clin Pathol; 1976 Sep; 29(9):770-2. PubMed ID: 789408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential.
    Byron PR; Mallick NP; Taylor G
    J Clin Pathol; 1976 Sep; 29(9):765-9. PubMed ID: 789407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis.
    Bonomini M; Forster S; De Risio F; Rychly J; Nebe B; Manfrini V; Klinkmann H; Albertazzi A
    Nephrol Dial Transplant; 1995; 10(9):1654-61. PubMed ID: 8559485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of haemodialysis on cellular immunodeficiency in uraemic patients (author's transl)].
    Reis HE; Heimsoth VH; Hirche H; Eitelhuber U
    Klin Wochenschr; 1974 May; 52(9):437-43. PubMed ID: 4409847
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in renal failure: depression of lymphocyte transformation by uraemia and methylprednisolone. Intra-individual consistency of lymphocyte responses to the in vitro suppressive effect of steroid.
    Langhoff E; Ladefoged J
    Int Arch Allergy Appl Immunol; 1984; 74(3):241-5. PubMed ID: 6724718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective immune and phagocytic functions in uraemia and renal transplantation.
    McIntosh J; Hansen P; Ziegler J; Penny R
    Int Arch Allergy Appl Immunol; 1976; 51(5):544-59. PubMed ID: 786902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in patients on long-term haemodialysis.
    Kauffman CA; Manzler AD; Phair JP
    Clin Exp Immunol; 1975 Oct; 22(1):54-61. PubMed ID: 1082396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)].
    Reis HE; Cremer W; Heimsoth VH; Graffe-Achelis C; Wetter O
    Klin Wochenschr; 1975 May; 53(10):467-72. PubMed ID: 1195651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are uraemic children immunologically compromised?
    Ensari C; Ekim M; Ikinciogullari A; Tümer N; Ensari A
    Nephron; 2001 Aug; 88(4):379-81. PubMed ID: 11474235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of prostaglandin E2 by macrophages in uraemia.
    Langhoff E; Blaehr H; Ladefoged J
    Nephrol Dial Transplant; 1991; 6(12):966-70. PubMed ID: 1798596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune mechanisms in uremia].
    Dobbelstein H
    Klin Wochenschr; 1975 May; 53(10):461-6. PubMed ID: 540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses in uremia.
    Boulton-Jones JM; Vick R; Cameron JS; Black PJ
    Clin Nephrol; 1973; 1(6):351-60. PubMed ID: 4799080
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte transformation in human plasma without addition of synthetic medium. A study of immune function in patients with chronic uraemia or diabetes mellitus.
    Sengar DP; Rashid A; Harris JE
    Int Arch Allergy Appl Immunol; 1976; 51(6):732-41. PubMed ID: 137217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
    Meissner S; Schwenke H; Witzel E; Achenbach H
    Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host immune status in uraemia. II. Serum factors and lymphocyte transformation.
    Stewart E; Miller TE
    Clin Exp Immunol; 1980 Jul; 41(1):123-9. PubMed ID: 6969146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.